Abstract:Porcine epidemic diarrhea (PED) has caused serious economic losses to the swine livestock industry. Due to the rapid variation in the PEDV) genome, especially the spike (S) protein, the cross-protection ability of antibodies between different vaccine strains is weakened. Hence, the rapid development of safe, broad-spectrum and highly effective attenuated PEDV vaccine still needs further research. Here, we found that the replacement of the S2 subunit had little effect on S protein immunogenicity. Moreover, the chimeric virus (YN-S2DR13), the S protein of the YN strain was replaced by the DR13 S2 subunit, which lost its trypsin tropism and increased its propagation ability (approximately 1 titer) in Vero cells. Then, the pathogenesis of YN-S2DR13 was evaluated in neonatal piglets. Importantly, quantitative real-time PCR, histopathology, and immunohistochemistry confirmed that the virulence of YN-S2DR13 was significantly reduced compared with that of YN. Immunization with YN-S2DR13 induced neutralizing antibodies against both YN and DR13 in weaned piglets. In vitro passaging data also showed that YN-S2DR13 had good genetic stability. Collectively, these results suggest that YN-S2DR13 has significant advantages as a novel vaccine candidate, including a capacity for viral propagation to high titers with no trypsin requirement and the potential to provide protection against both PEDV G1 and G2 strains infections. Our results also suggests that S2 subunit replacement using reverse genetics can be a rapid strategy for the rational design of live attenuated vaccines for PEDV. IMPORTANCE Emerging highly virulent porcine epidemic diarrhea virus (PEDV) G2 strains has caused substantial economic losses worldwide. Vaccination with a live attenuated vaccine is a promising method to prevent and control PED because it can induce a strong immune response (including T- and B-cell immunity). Previous studies have demonstrated that the S2 subunit of the PEDV spike (S) protein is the determinant of PEDV trypsin independence. Here, we evaluated the pathogenicity, tissue tropism, and immunogenicity of the chimeric virus (YN-S2DR13) via animal experiments. We demonstrated that YN-S2DR13 strain, as a trypsin independent strain, increased intracellular proliferation capacity, significantly reduced virulence, and induced broad-spectrum neutralization protection against PEDV G1 and G2 strains. In vitro passaging data also validated the stability of YN-S2DR13. Our results showed that generating a chimeric PEDV strain that is trypsin-independent by replacing the S2 subunit is a promising approach for designing a live attenuated vaccine for PEDV in the future.

Construction of Recombinant Adenovirus Co-expressing PEDV S1 and GM-CSF Proteins

Construction and Immunogenicity of Recombinant Adenovirus Expressing S Protein of Porcine Epidemic Diarrhea Disease Virus

Construction of Recombinant Adenovirus Expression Multiple Epitopes of Foot and Mouth Disease Virus

Construction and Identification of Recombinant Adenovirus Expression VP1 of Foot and Mouth Disease Virus

Construction and Expression of PEDV and TGEV Double Gene Co-Expressing Plasmid Pvaxd-Ps1-ts

Construction of Recombinant Adenovirus Co-expressing VP1-2A of Foot and Mouth Disease Virus and Porcine IL-2 and Its Immune Effects

Construction and immunogenicity of replicating recombinant human adenovirus serotype 4 expressing S protein of PEDV Chinese variant strain

Construction and expression of a recombinant plasmid containing the porcine epidemic diarrhea virus S1 gene delivered by Lactobacillus

Construction and identification of recombinant adenovirus containing FMDV 2A sequence,expressing GP5 and M protein of porcine reproduction and respiratory syndrome virus

Construction and Immunological Characterizations of the Recombinant Adenovirus Expressing Multi-Genes of the FMDV Serotype O

Enhancement of Mouse Immune Response by Recombinant Adenovirus Co-Expressing VP1-2A of Foot-and-mouth Disease Virus and Porcine IFN-α

Protection of Guinea Pigs and Swine by a Recombinant Adenovirus Expressing O Serotype of Foot-and-mouth Disease Virus Whole Capsid and 3C Protease.

Construction and immunogenicity of recombinant adenovirus tandem expressing M and GP5 of porcine reproductive and respiratory syndrome virus]

Construction and identification of attenuated Salmonella typhimurium harboring S gene of porcine epidemic diarrhea virus

Construction of the Recombinant Adenovirus Transfer Vector Containing VP1 Gene of FMDV and HSP70 Gene of M. Tuberculosis

Construction and Identification of Recombinant Adenovirus Coexpression PRRSV GP5 Gene and Porcine Interferon-γ Gene

Enhancing humoral and mucosal immune response of PED vaccine candidate by fusing S1 protein to nanoparticle multimerization

Construction of a Recombinant Lactococcus Lactis Strain Expressing a Variant Porcine Epidemic Diarrhea Virus S1 Gene and Its Immunogenicity Analysis in Mice.

Construction of Recombinant Adenoviral Vector Co-Expressing Vascular Cell Adhesion Molecules-1 and Enhanced Green Fluorescent Protein

Eukaryotic Expression of S1 and S2 Gene Fragments from SHpd/2012 Strain of Porcine Epidemic Diarrhea Virus

Development of a safe and broad-spectrum attenuated PEDV vaccine candidate by S2 subunit replacement.